Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MakeMyTrip Limited - Ordinary Shares (NQ:MMYT)

40.48 -4.45 (-9.90%)
Streaming Delayed Price Updated: 12:22 PM EDT, May 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MakeMyTrip Limited - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
MakeMyTrip (MMYT) Q4 2026 Earnings Transcript ↗
MakeMyTrip (MMYT) Q4 2026 Earnings Transcript 
Via The Motley Fool
News headline image
MakeMyTrip Q4 Earnings Call Highlights ↗
MakeMyTrip (NASDAQ:MMYT) executives said the company delivered higher full-year revenue and profitability in fiscal 2026 despite repeated disruptions to travel demand, including the West Asia conflict... 
Via MarketBeat
Topics Artificial Intelligence Earnings
News headline image
MakeMyTrip Limited to Report Fiscal 2026 Fourth Quarter and Full Year Financial & Operating Results on May 19, 2026
From MakeMyTrip Limited
Via Business Wire
News headline image
Earnings Scheduled For October 28, 2025 ↗
 
Via Benzinga
News headline image
What to Expect from MakeMyTrip's Earnings ↗
 
Via Benzinga
News headline image
A Look Into MakeMyTrip Inc's Price Over Earnings ↗
 
Via Benzinga
News headline image
MakeMyTrip Deepens AI-First Strategy with OpenAI Collaboration
From MakeMyTrip Limited
Via Business Wire
News headline image
$112 Million Vote of Confidence: This 12.8% Portfolio Bet Signals Conviction in MercadoLibre ↗
MercadoLibre operates a leading e-commerce and digital payments platform serving businesses and consumers across Latin America. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million. Is the Stock a Buy? ↗
This biopharma firm targets rare diseases with both approved therapies and a pipeline of clinical-stage treatments. 
Via The Motley Fool
News headline image
Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million. Is the Stock a Buy? ↗
This biopharma firm targets rare diseases with both approved therapies and a pipeline of clinical-stage treatments. 
Via The Motley Fool
News headline image
Why Did MakeMyTrip Stock Fall Today? ↗
MakeMyTrip Ltd. received target price cuts from Morgan Stanley and Citi following its third-quarter results that were below market expectations. 
Via Stocktwits
News headline image
MakeMyTrip (MMYT) Q3 2026 Earnings Call Transcript ↗
MakeMyTrip (MMYT) Q3 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
MakeMyTrip Limited to Report Fiscal 2026 Third Quarter Financial & Operating Results on January 21, 2026
From MakeMyTrip Limited
Via Business Wire
News headline image
MakeMyTrip Limited Announces Repurchase Right Notification for 0.00% Convertible Senior Notes due 2028
From MakeMyTrip Limited
Via Business Wire
News headline image
India's Silver Rush: Festival Frenzy and Global Flows Ignite Unprecedented Surge, With Unexpected Ripple Effects on Travel
India is currently experiencing an unprecedented surge in silver demand, a phenomenon primarily fueled by a potent combination of traditional festival buying and robust global market dynamics. This... 
Via MarketMinute
Topics ETFs Economy Electric Vehicles
News headline image
10 Consumer Discretionary Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
10 Consumer Discretionary Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Prosus Fuels India’s Travel Tech Ascent with $146M Ixigo Investment, Eyeing AI-Driven Future
New Delhi, India – November 3, 2025 – In a landmark move signaling deep confidence in India's burgeoning digital economy, Dutch technology investment giant Prosus (AMS: PRX) has made its inaugural... 
Via TokenRing AI
Topics Artificial Intelligence Economy
News headline image
This Small-Cap Fund Just Bet $7 Million on Root’s Comeback ↗
This Small-Cap Fund Just Bet $7 Million on Root’s Comeback 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Small-Cap Fund Just Dumped $7 Million in ADMA Stock — Here’s Why ↗
This Small-Cap Fund Just Dumped $7 Million in ADMA Stock — Here’s Why 
Via The Motley Fool
News headline image
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
MakeMyTrip (MMYT) Q2 2026 Earnings Call Transcript ↗
MakeMyTrip (MMYT) Q2 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
MakeMyTrip Limited to Report Fiscal 2026 Second Quarter Financial & Operating Results on October 28, 2025
From MakeMyTrip Limited
Via Business Wire
News headline image
MakeMyTrip Launches Multilingual GenAI Trip Planning Assistant, Making Travel Booking Conversational and Inclusive
From MakeMyTrip Limited
Via Business Wire
News headline image
India's Economic Ascent: Mutual Funds Soar, Aviation Market Takes Flight
India is currently experiencing a remarkable period of economic ascendancy, marked by significant growth across multiple sectors. Two prominent indicators of this robust expansion are the phenomenal... 
Via MarketMinute
Topics Economy
News headline image
MakeMyTrip Limited Announces Details of its Annual Shareholders Meeting
From MakeMyTrip Limited
Via Business Wire
News headline image
MakeMyTrip (MMYT) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Earnings Scheduled For July 22, 2025 ↗
 
Via Benzinga
News headline image
MakeMyTrip Limited to report Fiscal 2026 First Quarter Financial & Operating Results on July 22, 2025
From MakeMyTrip Limited
Via Business Wire
News headline image
In today's session, these stocks are experiencing unusual volume. ↗
Which stocks have an unusual volume on Tuesday? 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.